BetaGlue Therapeutics
Developer of a medical platform designed to provide a targeted approach in the treatment of cancer. The company offers a beta-emitting glue that delivers radionuclides directly into tumoral masses and...
Valuation
$0
Share Price
N/A
Total Raised
$49M
Last Round
N/A